Association Between Circulating GDF‐15 and Cardio‐Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial

BACKGROUND: Studies have suggested that sodium glucose co‐transporter 2 inhibitors exert anti‐inflammatory effects. We examined the association of baseline growth differentiation factor‐15 (GDF‐15), a marker of inflammation and cellular injury, with cardiovascular events, hospitalization for heart f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Taha, Li, Jingwei, Neuen, Brendon L., Arnott, Clare, Neal, Bruce, Perkovic, Vlado, Mahaffey, Kenneth W., Shaw, Wayne, Canovatchel, William, Hansen, Michael K., Heerspink, Hiddo J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075362/
https://www.ncbi.nlm.nih.gov/pubmed/34854308
http://dx.doi.org/10.1161/JAHA.121.021661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075362/
https://www.ncbi.nlm.nih.gov/pubmed/34854308
http://dx.doi.org/10.1161/JAHA.121.021661

Ejemplares similares